Page last updated: 2024-10-22

amifostine anhydrous and Gastric Diseases

amifostine anhydrous has been researched along with Gastric Diseases in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Junqueira-Júnior, J1
Junqueira, AF1
Medeiros, JV1
Barbosa, SH1
Nogueira, AC1
Mota, JM2
Santana, AP1
Brito, GA2
Ribeiro, RA2
Lima-Júnior, RC1
Souza, MH1
Soares, PM1
Menezes, AA1
Lemos, HP1
Cunha, FQ1
de Souza, MH1

Other Studies

2 other studies available for amifostine anhydrous and Gastric Diseases

ArticleYear
Role of capsaicin-sensitive primary afferent neurons and non-protein sulphydryl groups on gastroprotective effect of amifostine against ethanol-induced gastric damage in rats.
    Digestive diseases and sciences, 2011, Volume: 56, Issue:2

    Topics: Amifostine; Animals; Capsaicin; Dose-Response Relationship, Drug; Drug Administration Routes; Ethano

2011
Amifostine (Wr-2721) prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:1

    Topics: Adhesiveness; Amifostine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Enzyme Inh

2007